In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …

Vaccine-induced immune thrombotic thrombocytopenia (VITT; synonym, thrombosis with
thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies …

The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has
been extensively reported since the onset of the pandemic. The striking efforts of many …

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are
based on a range of novel platforms, with adenovirus-based approaches (like ChAdOx1 …

Within the first months of the COVID-19 vaccination campaign, previously healthy recipients
who developed severe thrombosis (often cerebral and/or splanchnic vasculature) and …

Abstract Vector-based SARS-CoV-2 vaccines have been associated with vaccine-induced
thrombosis with thrombocytopenia syndrome (VITT/TTS), but the causative factors are still …

Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-
immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct …

Both qualitative and quantitative platelet abnormalities are common in patients with
coronavirus disease 2019 (COVID-19) and they correlate with clinical severity and mortality …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a life-threatening syndrome
of aggressive thrombosis, often profound thrombocytopenia, and frequently overt …

Serious vaccine-associated side effects are very rare. Major complications of vaccines are
thrombocytopenia and thrombosis in which pathogenetic mechanism is consistent with …